Boothbay Fund Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-67,972
| Closed | -$2.69M | – | 1751 |
|
|
2024
Q1 | $2.69M | Sell |
67,972
-48,851
| -42% | -$1.94M | 0.05% | 336 |
|
|
2023
Q4 | $2.23M | Buy |
+116,823
| New | +$2.23M | 0.06% | 359 |
|
|
2021
Q3 | – | Sell |
-35,523
| Closed | -$320K | – | 2023 |
|
|
2021
Q2 | $320K | Sell |
35,523
-1,268
| -3% | -$11.4K | 0.01% | 1084 |
|
|
2021
Q1 | $390K | Buy |
36,791
+26,361
| +253% | +$279K | 0.01% | 877 |
|
|
2020
Q4 | $131K | Buy |
+10,430
| New | +$131K | ﹤0.01% | 987 |
|